Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups

NCT01654809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

900

Enrollment

OTHER_GOV

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: evaluated vaccine
BIOLOGICAL: imported compared vaccine
BIOLOGICAL: domestic compared vaccine

Sponsor

Beijing Center for Disease Control and Prevention